Dr. Ines Donangelo, MD

Dr. Donangelo practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Donangelo's NPI, 1497914550, was assigned on June 4, 2008. Dr. Donangelo graduated from State University of Rio de Janeiro Faculty of Medical Science in 1997. Dr. Donangelo's California license number on file is A109619.

Dr. Donangelo's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Donangelo's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Donangelo is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Donangelo to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Donangelo practices, 4 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Donangelo's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dmand AI has Dr. Donangelo's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, fluid and electrolyte imbalances, high cholesterol, hypercalcemia, osteoporosis and overactive thyroid among the conditions Dr. Donangelo treats.

CMS data shows 1,929 Medicare services from Dr. Donangelo across 10 procedure codes in 2024, for 601 Medicare patients. Medicare paid $122,599 for them.

CMS counts 601 Medicare patients who saw Dr. Donangelo in 2024. The largest group is 65 to 74, with 264 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Donangelo's median patient age at 61, with 67% women.

In 2024, Dr. Donangelo wrote 5,369 Medicare Part D claims for 525 patients. 48% of them were for generic drugs. CMS names the drug for 4,985 of them, across 69 drugs with 11 or more claims each, at $2,193,951 in total drug cost. In 2023, CMS named 4,583 claims across 64 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Donangelo for performance year 2024, reported as part of a group. Dr. Donangelo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Donangelo as offering telehealth.

Dmand AI links 6 papers to Dr. Donangelo, published from 2014 to 2020. Dr. Donangelo's most frequent co-authors are Tina Mosaferi, MD, John S. Adams, MD and Gregory Alan Brent, MD.

CMS Open Payments shows 6 general payments to Dr. Donangelo from 5 drug and device companies from 2016 to 2025. Education make up the largest share, 69% of the total. Amgen Inc. paid the most, $495.

Dr. Donangelo graduated from State University of Rio de Janeiro Faculty of Medical Science in 1997.

Dr. Donangelo is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.